tiprankstipranks
Trending News
More News >
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market
Advertisement

TransCode Therapeutics (RNAZ) Technical Analysis

Compare
429 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
TransCode Therapeutics’s (RNAZ) Moving Averages Convergence Divergence (MACD) indicator is 1.12, suggesting TransCode Therapeutics is a Sell.
TransCode Therapeutics’s (RNAZ) 20-Day exponential moving average is 12.96, while TransCode Therapeutics’s (RNAZ) share price is $14.92, making it a Buy.
TransCode Therapeutics’s (RNAZ) 50-Day exponential moving average is 12.07, while TransCode Therapeutics’s (RNAZ) share price is $14.92, making it a Buy.

TransCode Therapeutics (RNAZ) Pivot Points

Oct 19, 2025, 01:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.58
14.07
14.50
14.99
15.42
15.91
16.34
Fibonacci
14.07
14.42
14.64
14.99
15.34
15.56
15.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

TransCode Therapeutics (RNAZ) Moving Averages

Oct 19, 2025, 01:17 PM
Period
Simple
Exponential
MA5
14.56Buy
14.68Buy
MA10
14.05Buy
13.96Buy
MA20
12.30Buy
12.96Buy
MA50
11.32Buy
12.07Buy
MA100
10.07Buy
22.30Sell
MA200
45.97Sell
79.00Sell
TransCode Therapeutics’s (RNAZ) 10-Day exponential moving average is 13.96, while TransCode Therapeutics’s (RNAZ) share price is $14.92, making it a Buy.
TransCode Therapeutics’s (RNAZ) 100-Day exponential moving average is 22.30, while TransCode Therapeutics’s (RNAZ) share price is $14.92, making it a Sell.
TransCode Therapeutics’s (RNAZ) stock price is $14.92 and TransCode Therapeutics’s (RNAZ) 50-day simple moving average is 11.32, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) stock price is $14.92 and TransCode Therapeutics’s (RNAZ) 100-day simple moving average is 10.07, creating a Buy signal.
TransCode Therapeutics’s (RNAZ) stock price is $14.92 and TransCode Therapeutics’s (RNAZ) 200-day simple moving average is 45.97, creating a Sell signal.

TransCode Therapeutics (RNAZ) Technical Indicators

Oct 19, 2025, 01:17 PM
Name
Value
Implied Action
RSI (14)
71.07
Sell
STOCH (9,6)
41.41
Neutral
STOCHRSI (14)
45.60
Neutral
MACD (12,26)
1.12
Sell
ADX (14)
44.95
Neutral
Williams %R
-52.94
Buy
CCI (14)
93.40
Neutral
ATR (14)
1.39
-
Ultimate Oscillator
43.48
Neutral
ROC
43.14
Buy
TransCode Therapeutics’s (RNAZ) Relative Strength Index (RSI) is 71.07, creating a Sell signal.
TransCode Therapeutics’s (RNAZ) Trend Strength Indicator (ADX) is 44.95, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Commodity Channel Index (CCI) is 93.40, creating a Neutral signal.
TransCode Therapeutics’s (RNAZ) Price Rate of Change (ROC) is 43.14, creating a Buy signal.

FAQ

Is RNAZ a Buy, Hold, or Sell?
Based on RNAZ’s technical indicators, RNAZ is a Buy.
    What is RNAZ’s RSI (14)?
    RNAZ’s RSI (14) is 71.07, which suggests RNAZ is a Sell.
      What is RNAZ’s MACD?
      RNAZ’s MACD is 1.12, which suggests RNAZ is a Sell.
        What is RNAZ’s 5-day moving average?
        RNAZ’s 5-day moving average is 14.56, which suggests RNAZ is a Buy.
          What is RNAZ’s 20-day moving average?
          RNAZ 20-day moving average is 12.30, which suggests RNAZ is a Buy.
            What is RNAZ’s 50-day moving average?
            RNAZ’s 50-day moving average is 11.32, which suggests RNAZ is a Buy.
              What is RNAZ’s 200-day moving average?
              RNAZ’s 200-day moving average is 45.97, which suggests RNAZ is a Sell.
                What is RNAZ’s Williams % R (14)?
                RNAZ’s Williams % R (14) is -52.94, which suggests RNAZ is a Buy.
                  What is RNAZ’s CCI (14)?
                  RNAZ’s CCI (14) is 93.40, which suggests RNAZ is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis